RTSL
Rapid Therapeutic Science Laboratories, Inc.Company Information
- Company Name
- Rapid Therapeutic Science Laboratories, Inc.
- CIK
- CIK0001575659
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- RTSL: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- RTSL
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- 2020-12-28
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 4,266,667
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2023-08-14
- Price on filing date
- —
- 1-month reaction
- -85.71%
- 3-month reaction
- -86.00%
Balance Sheet
Values in millions ($)| Line item | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2020-06-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||||
Assets Current | ||||||||||||||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | ||||||
| Value Added Tax Receivable Current | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
Property Plant And Equipment | ||||||||||||||||||
| Property Plant And Equipment Gross | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | - | ||||||
| Property Plant And Equipment Owned Accumulated Depreciation | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | 0 | - | ||||||
| Accounts Payable Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Property Plant And Equipment Net | 1 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 0 | - | ||||||
Intangible Assets Net Excluding Goodwill | ||||||||||||||||||
| Intangible Assets Net Excluding Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Assets | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
Liabilities And Stockholders Equity | ||||||||||||||||||
| Common Stock Shares Subscriptions | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Accounts Payable And Accrued Liabilities Current And Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | - | - | ||||||
| Notes Payable Related Parties Classified Current | - | - | - | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Notes Payable Current | 1 | 1 | 1 | - | - | - | 0 | - | 0 | 0 | 0 | 1 | ||||||
| Other Notes Payable Current | - | 2 | 2 | 2 | 2 | 2 | 1 | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 2 | - | - | - | - | - | 1 | 0 | - | - | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Liabilities Current | 4 | 4 | 5 | 5 | 5 | 5 | 3 | 2 | 0 | 0 | 1 | 2 | ||||||
| Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Derivative Fair Value Of Derivative Liability | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Derivative Instruments And Hedges Liabilities | 0 | 0 | 1 | 1 | - | - | 1 | - | - | - | - | - | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | ||||||
| Convertible Debt Noncurrent | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | ||||||
Liabilities Noncurrent | ||||||||||||||||||
| Convertible Notes Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | - | ||||||
| Liabilities | 5 | 5 | 5 | 5 | 5 | 6 | 4 | 2 | 1 | 0 | 1 | 2 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Additional Paid In Capital | 8 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 7 | 7 | 4 | 3 | ||||||
| Stockholders Equity | -3 | -3 | -3 | -3 | -3 | -3 | -1 | -0 | 0 | 1 | -0 | -1 | ||||||
| Retained Earnings Accumulated Deficit | -10 | -10 | -10 | -10 | -10 | -10 | -9 | -7 | -7 | -6 | -5 | -4 | ||||||
| Treasury Stock Value | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | ||||||
| Liabilities And Stockholders Equity | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 1 | 1 | 1 | 1 | ||||||
| Series A Preferred Stock | - | 17 | 17 | 0 | 0 | 17 | 17 | 0 | 0 | - | - | - | ||||||
| Series B Preferred Stock | - | 2 | 2 | 0 | 0 | 2 | 2 | 0 | 0 | - | - | - | ||||||
| Series C Preferred Stock | - | 9 | 9 | 0 | 0 | 9 | 9 | 0 | 0 | - | - | - | ||||||
| Capitalized Contract Cost Accumulated Amortization | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | - | - | - | - | - | - | - | - | - | 17 | 100 | 100 | ||||||
| Preferred Stock Shares Issued | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 800 | 800 | 800 | 800 | 800 | 800 | 800 | 750 | 750 | 750 | 750 | 750 | ||||||
| Shares Outstanding | 9 | 8 | 8 | 8 | 8 | 8 | 8 | 194 | 194 | 193 | 176 | 162 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialRapid Therapeutic Science Laboratories, Inc. (RTSL) — SEC Financial Statements & Analysis
Rapid Therapeutic Science Laboratories, Inc. (RTSL) is a pharmaceutical preparations company, incorporated in NV. Rapid Therapeutic Science Laboratories, Inc. trades on OTC as: RTSL. Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s most recent SEC filing is a Form 10-Q for the period ended 2023-06-30, filed with the SEC on 2023-08-14. Based on that filing, Rapid Therapeutic Science Laboratories, Inc. carries a market cap of $532.36K, a P/E ratio of 50.14x, a P/B ratio of -0.19x, a P/S ratio of 325360.84x, an enterprise value of $3.83M, and an EV/EBITDA multiple of -7.82x. On profitability, it posts an operating margin of -4400062.00%, a net margin of -4400062.00%, a Return on Equity (ROE) of -0.38%, a Return on Assets (ROA) of 0.47%, and a Return on Invested Capital (ROIC) of -1315.68%. Per share, it reports EPS of $0.00, free cash flow per share of $-0.03, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -100.00% year-over-year, net income growth of -100.48% year-over-year, and EPS growth of -100.45% year-over-year. On the balance sheet, it maintains a current ratio of 0.07x, a quick ratio of 0.02x, working capital of $-4.11M, a debt-to-equity ratio of -1.76x, a debt ratio of 2.32, an interest coverage ratio of -0.98x, free cash flow of $-256.37K (TTM), and net debt of $3.30M. Figures sourced from SEC EDGAR.
- Market Cap
- $532.36K
- P/E TTM
- 50.14x
- EPS TTM
- $0.00
- P/B TTM
- -0.19x
- ROE TTM
- -0.38%
- ROA TTM
- 0.47%
- Debt To Equity
- -1.76x
- Free Cash Flow TTM
- $-256.37K
- Net Revenue TTM Growth 1Y
- -100.00%
Data as of 2023-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Rapid Therapeutic Science Laboratories, Inc. in?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) operates in the Pharmaceutical Preparations industry.
What exchange does RTSL trade on?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) trades on the OTC.
Where is Rapid Therapeutic Science Laboratories, Inc. incorporated?
Rapid Therapeutic Science Laboratories, Inc. is incorporated in NV.
When was Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s most recent SEC filing?
Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s most recent SEC filing is a Form 10-Q for the period ended 2023-06-30, filed with the SEC on 2023-08-14.
What is RTSL's market cap?
Rapid Therapeutic Science Laboratories, Inc. (RTSL) has a market capitalization of $532.36K as of 2023-06-30.
What is RTSL's P/E ratio?
Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s trailing twelve month P/E ratio is 50.14x as of 2023-06-30.
What is RTSL's EPS (earnings per share)?
Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s trailing twelve month EPS is $0.00 as of 2023-06-30.
What is RTSL's ROE (return on equity)?
Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s trailing twelve month Return on Equity (ROE) is -0.38% as of 2023-06-30.
What is RTSL's ROA (return on assets)?
Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s trailing twelve month Return on Assets (ROA) is 0.47% as of 2023-06-30.
What is RTSL's ROIC (return on invested capital)?
Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s trailing twelve month Return on Invested Capital (ROIC) is -1315.68% as of 2021-06-30.
What is RTSL's EV/EBITDA?
Rapid Therapeutic Science Laboratories, Inc. (RTSL)'s trailing twelve month EV/EBITDA is -7.82x as of 2023-06-30.